Safety and efficacy of immune checkpoint inhibitors (ICIs) in cancer patients with HIV, hepatitis B, or hepatitis C viral infection - Shah, Neil J.; Al-Shbool, Ghassan; Blackburn, Matthew; Cook, Michael; Belouali, Anas; Liu, Stephen V.; Madhavan, Subha; He, Aiwu Ruth; Atkins, Michael B.; Gibney, Geoffrey T.; Kim, Chul (Journal for immunotherapy of cancer, 2019)
Keywords: Adult; Aged; Aged, 80 and over; Analysis; Anti-HIV agents; Antineoplastic Agents, Immunological - administration & dosage; Antineoplastic Agents, Immunological - adverse effects; Antineoplastic Agents, Immunological - therapeutic use; Atezolizumab; Avelumab; Bictegravir; Biomarkers; Biopsy; Cancer; Cancer patients; Cancer therapies; Carboplatin; Care and treatment; Chemotherapy; Clinical trials; Clinical/Translational Cancer Immunotherapy; Cobicistat; Darunavir; Dolutegravir; Durvalumab; Elvitegravir; Emtricitabine; Female; Health aspects; Hepatitis B; Hepatitis B (HBV); Hepatitis B - complications; Hepatitis B - diagnosis; Hepatitis C; Hepatitis C (HCV); Hepatitis C - complications; Hepatitis C - diagnosis; Hepatitis C virus; HIV; HIV infections; HIV Infections - complications; HIV Infections - diagnosis; HIV patients; Hospitals; Human immunodeficiency virus; Human immunodeficiency virus (HIV); Humans; Immune checkpoint inhibitors; Immune checkpoint inhibitors (ICI); Immune related adverse events (irAEs); Immunotherapy; Infection; Infections; Ipilimumab; Liver cancer; Lung cancer; Lymphoma; Male; Middle Aged; Molecular Targeted Therapy - adverse effects; Molecular Targeted Therapy - methods; Neoplasm Staging; Neoplasms - complications; Neoplasms - diagnosis; Neoplasms - drug therapy; Neoplasms - etiology; Nivolumab; Odds Ratio; Patients; Pembrolizumab; Pemetrexed; Raltegravir; Research Article; Retrospective Studies; Rilpivirine; T cells; Tomography, X-Ray Computed; Toxicity; Treatment Outcome; Tumors; Viral infections; Hepatitis C (HCV); Hepatitis B (HBV); Immune checkpoint inhibitors (ICI); Immune related adverse events (irAEs); Human immunodeficiency virus (HIV)